Paper41547732
Protective effects of recombinant depolymerase Dep44 against K64-CRKP-induced pulmonary infection in a murine infection model.
Yan T and 6 others. BMC Microbiol, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Protective effects of recombinant depolymerase Dep44 against K64-CRKP-induced pulmonary infection in a murine infection model. Papers, record 41547732. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41547732
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Protective effects of recombinant depolymerase Dep44 against K64-CRKP-induced pulmonary infection in a murine infection model.
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Klebsiella pneumoniae | Major topic |
| Klebsiella Infections | Major topic |
| Glycoside Hydrolases | Major topic |
| Carbapenem-Resistant Enterobacteriaceae | Major topic |
| Animals | |
| Mice | |
| Disease Models, Animal | |
| Recombinant Proteins | |
| Bacteriophages | |
| Female | |
| Lung | |
| Anti-Bacterial Agents | |
| Mice, Inbred BALB C |
Source PubMed
References22
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 37653407 | A novel phage carrying capsule depolymerase effectively relieves pneumonia caused by multidrug-resistant Klebsiella aerogenes. | J Biomed Sci | 2023 | https://conductscience.org/library/papers/37653407 | PubMed |
| 2 | 37538841 | Phage resistance formation and fitness costs of hypervirulent Klebsiella pneumoniae mediated by K2 capsule-specific phage and the corresponding mechanisms. | Front Microbiol | 2023 | https://conductscience.org/library/papers/37538841 | PubMed |
| 3 | 39754049 | Emergence and clinical challenges of ST11-K64 carbapenem-resistant Klebsiella pneumoniae: molecular insights and implications for antimicrobial resistance and virulence in Southwest China. | BMC Infect Dis | 2025 | https://conductscience.org/library/papers/39754049 | PubMed |
| 4 | 37949739 | Chasing the landscape for intrahospital transmission and evolution of hypervirulent carbapenem-resistant Klebsiella pneumoniae. | Sci Bull (Beijing) | 2023 | https://conductscience.org/library/papers/37949739 | PubMed |
| 5 | 38715095 | Therapeutic efficacy of a K5-specific phage and depolymerase against Klebsiella pneumoniae in a mouse model of infection. | Vet Res | 2024 | https://conductscience.org/library/papers/38715095 | PubMed |
| 6 | 38850533 | A spatiotemporal map of co-receptor signaling networks underlying B cell activation. | Cell Rep | 2024 | https://conductscience.org/library/papers/38850533 | PubMed |
| 7 | 32448764 | Carbapenem Resistance-Encoding and Virulence-Encoding Conjugative Plasmids in Klebsiella pneumoniae. | Trends Microbiol | 2021 | https://conductscience.org/library/papers/32448764 | PubMed |
| 8 | 33853672 | Assessment of the microbiome during bacteriophage therapy in combination with systemic antibiotics to treat a case of staphylococcal device infection. | Microbiome | 2021 | https://conductscience.org/library/papers/33853672 | PubMed |
| 9 | 38391556 | Great Plasticity in a Great Pathogen: Capsular Types, Virulence Factors and Biofilm Formation in ESBL-Producing Klebsiella pneumoniae from Pediatric Infections in Uruguay. | Antibiotics (Basel) | 2024 | https://conductscience.org/library/papers/38391556 | PubMed |
| 10 | 39035437 | Emerging roles of bacteriophage-based therapeutics in combating antibiotic resistance. | Front Microbiol | 2024 | https://conductscience.org/library/papers/39035437 | PubMed |
| 11 | 31961299 | Novel Subclone of Carbapenem-Resistant Klebsiella pneumoniae Sequence Type 11 with Enhanced Virulence and Transmissibility, China. | Emerg Infect Dis | 2020 | https://conductscience.org/library/papers/31961299 | PubMed |
| 12 | 33897652 | Virulence Factors in Hypervirulent Klebsiella pneumoniae. | Front Microbiol | 2021 | https://conductscience.org/library/papers/33897652 | PubMed |
| 13 | 33545392 | New insights into regulatory B cells biology in viral, bacterial, and parasitic infections. | Infect Genet Evol | 2021 | https://conductscience.org/library/papers/33545392 | PubMed |
| 14 | 37419417 | Characterization of bacteriophage BUCT631 lytic for K1 Klebsiella pneumoniae and its therapeutic efficacy in Galleria mellonella larvae. | Virol Sin | 2023 | https://conductscience.org/library/papers/37419417 | PubMed |
| 15 | 36426942 | Mechanism of CD79A and CD79B Support for IgM+ B Cell Fitness through B Cell Receptor Surface Expression. | J Immunol | 2022 | https://conductscience.org/library/papers/36426942 | PubMed |
| 16 | 33535705 | Identification of a Depolymerase Specific for K64-Serotype Klebsiella pneumoniae: Potential Applications in Capsular Typing and Treatment. | Antibiotics (Basel) | 2021 | https://conductscience.org/library/papers/33535705 | PubMed |
| 17 | 9767057 | Klebsiella spp. as nosocomial pathogens: epidemiology, taxonomy, typing methods, and pathogenicity factors. | Clin Microbiol Rev | 1998 | https://conductscience.org/library/papers/9767057 | PubMed |
| 18 | 33868238 | Revisiting the Coreceptor Function of Complement Receptor Type 2 (CR2, CD21); Coengagement With the B-Cell Receptor Inhibits the Activation, Proliferation, and Antibody Production of Human B Cells. | Front Immunol | 2021 | https://conductscience.org/library/papers/33868238 | PubMed |
| 19 | 35914009 | Capsule type defines the capability of Klebsiella pneumoniae in evading Kupffer cell capture in the liver. | PLoS Pathog | 2022 | https://conductscience.org/library/papers/35914009 | PubMed |
| 20 | 39429194 | Synergy of bacteriophage depolymerase with host immunity rescues sepsis mice infected with hypervirulent Klebsiella pneumoniae of capsule type K2. | Virulence | 2024 | https://conductscience.org/library/papers/39429194 | PubMed |
Data2
The data bank entries PubMed's record names. Trial numbers are under Trials.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41547732
GET https://conductscience.org/api/papers/v1/41547732/references?page=2